About AvKARE
AvKARE is a Healthcare company based in Pulaski (United States) founded in 2007, and was acquired by Amneal in December 2019. Pharmaceuticals and infection control products are distributed by AvKARE. The company has 108 employees. Its focus areas include Pharmaceutical Distributors and Diversified. Its legal entity is AVKARE, INC. Its competitors include AmerisourceBergen, Renee and Apothkary; 2 of its 3 listed competitors have raised funding.
Company details
AvKARE was founded in 2007 and is headquartered in Pulaski, United States. Operations are centered on the distribution of pharmaceuticals and infection control products within the healthcare sector. A variety of generic drugs and related supplies are provided to pharmacies, hospitals, and other facilities across the country. The companys domain, avkare.com, supports these distribution activities, ensuring compliance with industry standards.
- Headquarters Pulaski, United States
- Employees 108
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website avkare.com
- Social LinkedIn X Facebook
- Acquired by Amneal (Dec 2019)
- Legal Name Avkare, Inc.
Funding Insights of AvKARE
- Total Rounds 1
- Last Round Debt – Conventional β $210M
- First Round $210M
(Jan 2020)
All 1 funding rounds of AvKARE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2020 | $210M | Debt – Conventional | β | β | β |
1 investors in total: 1 institutional.
Investors in AvKARE
AvKARE has secured backing from 1 investor. Prominent investors backing the company include Amneal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | amneal.com | Bridgewater, United States |
Investor details for AvKARE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AvKARE
6 people are tracked at AvKARE (3 in leadership, 3 in team); the tracked headcount is 108.
| Name | Role | Group |
|---|---|---|
Troy Mizell | President & Ceo | Leadership |
Matt Locke | CTO | Leadership |
Kerry Dilley | Executive Vice President | Leadership |
Marcus Manno | Senior Solutions Architect | Team |
Rick D. | EVP Operations And Technology | Team |
Kaitlin Lessieu | EVP Of Strategic Initiatives & Execution | Team |
Complete people profiles for AvKARE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AvKARE
3 dated milestones of AvKARE across 13 years, from founding to its latest funding, stage changes and deals.
- Founded AvKARE is founded.
- Exit Acquired by Amneal.
- Funding First funding round of $210.0M.
Competitors of AvKARE
AvKARE has 3 listed competitors in our database, 2 of them funded. They include AmerisourceBergen, Renee and Apothkary.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | ||
| renee.com | 2021 | Los Angeles, United States | $8.2M | Diversified drugs are distributed by Renee in the United States. | ||
| apothekary.co | 2018 | Falls Church, United States | $11.2M | Provides herbal formulas for stress relief, energy, mood, and wellness support. |
Detailed competitors of AvKARE
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AvKARE
The website of AvKARE (avkare.com) receives about 4.6K visits a month.
- Monthly visits4.6K
▼ 15.8% vs previous month
Websites whose visitors overlap most with AvKARE. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioject.com | 100% | View details | |||
fda.report | fda.report | 97% | #460,872 | β | |
freestyleprovider.abbott | freestyleprovider.abbott | 58% | #675,516 | β |
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as AvKARE (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avkare
Complete news archive for AvKARE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AvKARE
AvKARE was founded in 2007 and raised its 1st funding round 13 years after it was founded.
AvKARE is headquartered in Pulaski, United States.
AvKARE has 108 employees.
AvKARE was founded in 2007 and is headquartered in Pulaski, United States. Operations are centered on the distribution of pharmaceuticals and infection control products within the healthcare sector. A variety of generic drugs and related supplies are provided to pharmacies, hospitals, and other facilities across the country. The companys domain, avkare.com, supports these distribution activities, ensuring compliance with industry standards.
AvKARE's top competitors include AmerisourceBergen, Renee and Apothkary.
AvKARE has 1 investor. Key investors include Amneal.
AvKARE operates through Avkare, Inc..
Yes. AvKARE was acquired by Amneal in December 2019.

